Put companies on watchlist
STRABAG SE
ISIN: AT000000STR1
WKN: A0M23V
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

STRABAG SE · ISIN: AT000000STR1 · EQS - adhoc news (63 News)
Country: Austria · Primary market: Austria · EQS NID: 1897999
07 May 2024 10:36PM

STRABAG planning to acquire parts of VAMED Group together with PORR


EQS-Ad-hoc: STRABAG SE / Key word(s): Acquisition
STRABAG SE: STRABAG planning to acquire parts of VAMED Group together with PORR

07-May-2024 / 22:36 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


STRABAG planning to acquire parts of VAMED Group together with PORR
  • Acquisition of technical operations management and construction projects divisions of Vienna General Hospital (AKH Wien), Austrian project development business and spa holdings
  • Purchase agreement signed by joint STRABAG SE and PORR AG holding company, total purchase price around € 90 million
  • Finalisation of transaction on part of STRABAG SE subject to approval by Supervisory Board
The Management Board of STRABAG SE hereby discloses that STRABAG SE, together with PORR AG, intends to acquire parts of the VAMED Group via a joint holding company for a total purchase price of around € 90 million. The seller is VAMED AG, which is majority-owned by Fresenius SE & Co. KGaA of Germany. The object of the transaction is VAMED-KMB Krankenhausmanagement und Betriebsführungsges.m.b.H. (VKMB) and VAMED Standortentwicklung und Engineering GmbH (VSG), comprising the technical operations management and construction projects divisions of Vienna General Hospital (AKH Wien), the Austrian project development business and VAMED’s spa holdings in Austria.

The purchase agreement was signed today. PORR AG and STRABAG SE will each hold half of the buyer company. STRABAG SE still requires approval from its Supervisory Board in order to finalise the transaction.

The transaction is also subject to regulatory approval, including approval by the relevant competition authorities.
 


End of Inside Information

07-May-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com


Language: English
Company: STRABAG SE
Donau-City-Straße 9
1220 Vienna
Austria
Phone: +43 1 22422 – 1089
Fax: +43 1 22422 - 1177
E-mail: investor.relations@strabag.com
Internet: www.strabag.com
ISIN: AT000000STR1, AT0000A36HJ5
Listed: Vienna Stock Exchange (Official Market)
EQS News ID: 1897999

 
End of Announcement EQS News Service

1897999  07-May-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1897999&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - STRABAG SE
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.